HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Proteomic analysis of renal diseases: unraveling the pathophysiology and biomarker discovery.

Abstract
Current biomedical applications of proteomics have been conducted with four main objectives: to better understand the normal biology and physiology of cells, microorganisms, tissues and organs; to explore the pathogenic mechanisms and better understand the pathophysiology of medical diseases; to identify novel biomarkers for early disease detection, prediction and prognosis; and to define new therapeutic targets, drugs and vaccines. This review focuses predominantly on proteomic applications to unravel the pathophysiology and to define novel biomarkers for various renal diseases (i.e., glomerular diseases, tubulointerstitial diseases, renal vascular disorders and renal cancers). In addition, proteomic evaluations of renal transplantation and renal replacement therapy (for acute renal failure and end-stage renal disease) are summarized. Personal opinion, future perspectives and information resources for the field of renal and urinary proteomics are provided.
AuthorsVisith Thongboonkerd
JournalExpert review of proteomics (Expert Rev Proteomics) Vol. 2 Issue 3 Pg. 349-66 (Jun 2005) ISSN: 1744-8387 [Electronic] England
PMID16000082 (Publication Type: Journal Article, Review)
Chemical References
  • Biomarkers
Topics
  • Biomarkers (analysis)
  • Humans
  • Kidney Diseases (physiopathology)
  • Kidney Failure, Chronic (therapy)
  • Kidney Neoplasms (physiopathology)
  • Proteomics (methods, trends)
  • Renal Replacement Therapy

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: